First-line nitrosourea-based chemotherapy in symptomatic non-resectable supratentorial pure low-grade astrocytomas

European Journal of Neurology

Volumn 12, Issue 9, 2005, Pages 685-690

  Frenay, M P ^b   Fontaine, D ^a   Vandenbos, F ^a   Lebrun, Christine ^a  

^a PASTEUR HOSPITAL   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Chemotherapy; Gliomas; Low grade astrocytomas; Prognosis

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CARBAMAZEPINE; CISPLATIN; CONTRAST MEDIUM; ETOPOSIDE; FOTEMUSTINE; GABAPENTIN; GADOLINIUM; LOMUSTINE; NITROSOUREA DERIVATIVE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PHENYTOIN; PROCARBAZINE; VALPROIC ACID; VIGABATRIN; VINCRISTINE;

ADULT; ARTICLE; ASTROCYTOMA; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; BRAIN BIOPSY; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG EFFICACY; EPILEPSY; FEMALE; FOLLOW UP; GLIOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEIZURE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CEREBRAL CORTEX; COMBINED MODALITY THERAPY; DRUG THERAPY; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NITROSOUREA COMPOUNDS; RETROSPECTIVE STUDIES;

EID: 24744434138     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2005.01028.x     Document Type: Article

References (27)

1. Brada M, Viviers L, Abson C et al. (2003). Phase II of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715-1721.
2. Brown PD, Buckner JC, Uhm JH, Shaw EG (2003). The neurocognitive effects of radiation in adult low-grade glioma patients. Neuro-oncol 5:161-167.
3. Buckner JC, Gesme D Jr, O'Fallon JR et al. (2003). Phase II trial of procarbazine, lomustine an vincristine as initial therapy for patients with low-grade oligodendrogliomas or oligoastrocytomas: efficacy and associations with chromosomal abnormalities. J Clin Oncol 21:251-255.
4. Cairncross JG (2000). Understanding low-grade glioma. A decade of progress. Neurology 54:1402-1403.
5. Cairncross, G, Mc Donald D, Ludwin S et al. (1994). Chemotherapy for anaplastic oligodendrogliomas. J Clin Oncol 12:2013-2021.
6. Cairncross JG, Ueki K, Zlatescu MC et al. (1998). Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473-1479.
7. De Angelis LM (2001). Brain tumors. N Engl J Med 344:114-123.
8. Duffau H, Capelle Y, Denvil D et al. (2003). Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J Neurosurg 98:764-778.
9. Eagan RT, Dinapoli RP, Herman RC et al. (1982) Combination carmustine (BCNU) and dihydrogalactilol in the treatment of primary brain tumors recurring after irradiation. Cancer Treatment Reports 66:1647-1649.
10. Eyre HJ, Eltringham JR, Crowley J, Morantz RA (1993). A randomized trial of radiotherapy vs RT + CCNU for incompletely resected low grade gliomas: Southwest Oncology Group Study. J Neurosurg 78:909-914.
11. Frénay M, Lebrun C, Lonjon M et al. (2000). Up-front chemotherapy with fotemustine (F)/cisplatine (CDDP)/etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas. Eur J Cancer 36:1026-1031.
12. Karim AB, Cornu P, Bleehen N et al. (1998). Immediate postoperative radiotherapy in low grade glioma improves progression free survival, but not overall survival: preliminary results of an EORTC/MRC randomized phase III study. Proc Am Soc Clin Oncol 17:400a.
13. Karim AB, Afra D, Cornu P et al. (2002). Randomized trial on the efficacy of radiotherapy for cerebral low-grade gliomas in adults: EORTC 22845 with the Medical Research Council Study BRO4: an interim analysis. Int J Radiother Oncol Biol Phys 52:316-324.
14. Keles GE, Lamborn KR, Berger MS (2001). Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735-745.
15. Kleihues P, Cavenee WK (2000). World Health Organization. In: Kleihues P, Cavenee WK, eds. Tumors of the Nervous System, Pathology and Genetic Classification of Tumors. IARC Press, Lyon.
16. Klein M, Heimans JJ, Aaronson NK et al. (2002). Effect of radiotherapy and other treatment-related factors on midterm to long term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360:1361-1368.
17. Kreth FW, Faist M, Warnke PC et al. (1995). Interstitial radiosurgery of low-grade gliomas. J Neurosurg 82:418-429.
18. Laws ER, Taylor, WF, Clifton MB et al. (1984). Neurosurgical management of low grade astrocytoma of the cerebral hemispheres. J Neurosurg 61:665-673.
19. Lo SS, Cho KH, Hernandez WL, Kossow RJ, Lee CK, Clark HB (2001). Does the extent of surgery have an impact on the survival of patients who receive postoperative radiation therapy for supratentorial low-grade gliomas? Int J Cancer 96 (Suppl.):71-78.
20. Mason WP, Krol GS, De Angelis L (1996). Low-grade oligodendrogliomas responds to chemotherapy. Neurology 46:203-207.
21. Nakamura M, Konishi N, Tsunoda S et al. (2000) Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults. Oncology 58:108-116.
22. Olson JD, Riedel E, De Angelis L (2000). Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54:1442-1448.
23. Pace A, Vidiri A, Galie E et al. (2003). Temozolomide chemotherapy for progressive low-grade gliomas. Clinical benefits and radiological response. Ann Oncol 14:1722-1726.
24. Quinn JA, Reardon DA, Friedman AH et al. (2003) Phase II trial of temozolomide in patients with progressive low-grade gliomas. J Clin Oncol 21:646-651.
25. Scerrati M, Roselli R, Iacoangeli M, Pompucci A, Rossi GF (1996). Pronostic factors in low grade (WHO II) gliomas of the cerebral hemispheres: the role of surgery. J Neurol Neurosurg Psychiatry 61:291-296.
26. Surma-aho O, Niemella M, Vilkki J et al. (2001). Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 56:1285-1290.
27. Van den Bent M, Chinot OL, Cairncross JG (2003). Recent developments in the molecular characterization and treatment of oligodendroglial tumors. Neuro-oncol 5:128-138.